ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

27,769Medicare Part D Prescriptions Filled, Including Refills

Rank: 13 out of 3734

$1.5M Total Retail Price of All Prescriptions

Rank: 18 out of 3734

673 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

14% of this provider’s 673 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

7% of this provider’s 673 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Risky Drugs to Seniors

1% of this provider’s 23,332 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$54 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 19.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
OMEPRAZOLE 1,533 1,305 1 4
LEVOTHYROXINE SODIUM 1,229 1,070 2 2
FUROSEMIDE 992 833 3 7
CITALOPRAM HBR 740 715 4 16
AMLODIPINE BESYLATE 674 628 5 5
SIMVASTATIN 567 442 6 1
IPRATROPIUM-ALBUTEROL 562 482 7 98
TRAMADOL HCL 490 398 8 20
DONEPEZIL HCL 457 456 9 25
METOPROLOL TARTRATE 447 424 10 6
POLYETHYLENE GLYCOL 3350 444 389 11 53
QUETIAPINE FUMARATE 436 369 12 82
KLOR-CON M20 410 366 13 48
JANTOVEN 409 383 14 76
GABAPENTIN 399 280 15 17
RISPERIDONE 387 314 16 62
LISINOPRIL 356 306 17 3
PREDNISONE 354 328 18 42
MIRTAZAPINE 344 318 19 45
TAMSULOSIN HCL 331 255 20 29
POTASSIUM CHLORIDE 331 287 20 19
METFORMIN HCL 300 204 22 8
NAMENDA 294 289 23 44
METOPROLOL SUCCINATE 284 272 24 14
WARFARIN SODIUM 257 257 25 10
SERTRALINE HCL 231 201 26 18
HYDROCODONE-ACETAMINOPHEN 223 135 S3 27 12
CIPROFLOXACIN HCL 205 186 28 77
CARVEDILOL 203 167 29 30
ALLOPURINOL 203 190 29 33
XARELTO 192 173 31 381
KLOR-CON M10 192 173 31 115
DIVALPROEX SODIUM 185 115 33 99
GLIPIZIDE ER 169 150 34 119
TRAZODONE HCL 169 143 34 49
NYSTATIN-TRIAMCINOLONE 166 141 36 200
AMIODARONE HCL 166 166 36 203
BUMETANIDE 152 150 38 78
ISOSORBIDE MONONITRATE ER 151 151 39 34
ATENOLOL 150 144 40 13
BENZTROPINE MESYLATE 146 53 R 41 173
ALENDRONATE SODIUM 146 145 41 26
SEROQUEL 144 119 43 161
SPIRONOLACTONE 143 87 44 80
LANTUS 142 131 45 54
OLANZAPINE 139 121 46 106
PRAVASTATIN SODIUM 138 74 47 15
CARBIDOPA-LEVODOPA 137 110 48 92
HYDROCHLOROTHIAZIDE 136 124 49 9
ADVAIR DISKUS 134 107 50 35
MELOXICAM 130 114 51 52
GLIPIZIDE XL 129 127 52 85
ALBUTEROL SULFATE 128 128 53 128
FLUOXETINE HCL 122 121 54 61
DIGOXIN 119 107 55 43
DIOVAN 118 117 56 31
NITROFURANTOIN MONO-MACRO 118 101 56 196
PHENYTOIN SODIUM EXTENDED 118 106 56 149
GENTAMICIN SULFATE 109 97 59 382
PANTOPRAZOLE SODIUM 108 108 60 22
AGGRENOX 107 103 61 182
PRADAXA 105 103 62 205
SUCRALFATE 105 85 62 225
DOXAZOSIN MESYLATE 104 91 64 100
PLAVIX 101 92 65 39
ABILIFY 100 77 66 159
METOLAZONE 100 90 66 174
MOMETASONE FUROATE 100 91 66 275
FLUTICASONE PROPIONATE 98 51 69 46
AZITHROMYCIN 98 91 69 38
NYSTOP 96 71 71 187
SPIRIVA 95 76 72 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 95 77 72 117
LEVETIRACETAM 94 61 74 105
PAROXETINE HCL 92 86 75 59
JANUVIA 90 71 76 50
CYMBALTA 88 41 77 67
BUPROPION HCL 86 73 78 404
TRAVATAN Z 85 85 79 278
LEVOFLOXACIN 83 78 80 116
NAFTIN 81 71 81 486
ACTOS 80 62 82 110
IPRATROPIUM BROMIDE 80 80 82 220
CLOPIDOGREL 79 74 84 23
NOVOLIN R 79 58 84 215
FINASTERIDE 77 65 86 88
FAMOTIDINE 74 74 87 60
LATANOPROST 74 68 87 197
PREMARIN 73 61 R 89 246
COMBIVENT 73 65 89 156
METRONIDAZOLE 73 69 89 321
LIDODERM 73 68 89 170
AMLODIPINE BESYLATE-BENAZEPRIL 72 26 93 56
GLIPIZIDE 72 44 93 57
NYSTATIN 72 70 93 162
ESCITALOPRAM OXALATE 69 60 96 68
VENLAFAXINE HCL 68 37 97 213
OLANZAPINE ODT 68 68 97 428
DOXYCYCLINE HYCLATE 67 48 99 147
KLOR-CON 67 67 10 99 507
CEFPODOXIME PROXETIL 67 63 99 507
TRIAMCINOLONE ACETONIDE 67 26 99 131
DILTIAZEM 24HR CD 67 67 99 97
ATORVASTATIN CALCIUM 66 41 104 11
SANTYL 65 56 105 226
OXYBUTYNIN CHLORIDE 62 26 106 151
NEXIUM 60 57 107 36
RANITIDINE HCL 60 46 107 32
FLUCONAZOLE 59 47 109 259
COLCRYS 59 44 109 216
FENTANYL 58 47 S2 111 65
CLONIDINE 58 45 111 364
MORPHINE SULFATE 58 55 S2 111 220
SPS 56 37 114 357
OXYBUTYNIN CHLORIDE ER 55 55 115 141
BUDESONIDE 54 33 116 231
HUMALOG 53 48 117 146
BENAZEPRIL HCL 53 53 117 103
KLOR-CON 10 52 52 119 140
HUMULIN R 51 38 120 273
LEVEMIR 50 31 121 202
OXYCODONE HCL 50 45 S2 121 58
AMPICILLIN TRIHYDRATE 50 45 121 411
HALOPERIDOL 50 13 121 212
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 14, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.